首页|宣肺止嗽合剂治疗急性支气管炎(风邪犯肺证)的有效性及安全性的随机、安慰剂对照、双盲、多中心临床研究

宣肺止嗽合剂治疗急性支气管炎(风邪犯肺证)的有效性及安全性的随机、安慰剂对照、双盲、多中心临床研究

扫码查看
目的 评价宣肺止嗽合剂治疗急性支气管炎(风邪犯肺证)的安全性和有效性。方法 采用随机、双盲、安慰剂对照研究,在19个平行中心进行观察,将240例急性支气管炎(风邪犯肺证)患者分为试验组和对照组,每组120例。试验组口服宣肺止嗽合剂,对照组口服宣肺止嗽合剂模拟剂,疗程均为7 d。比较两组咳嗽视觉模拟(VAS)评分、咳嗽缓解和消失情况、临床疗效和安全性。结果 最终完成试验者232例,其中试验组118例,对照组114例。治疗后,两组咳嗽VAS评分降低,且试验组降低更为明显,两组上述指标在治疗第4天后较基线的差值、治疗后较基线的差值均有统计学意义(P<0。05或P<0。01)。试验组咳嗽缓解率及消失率均明显高于对照组(P<0。01)。PPS与FAS分析结果一致。试验组治疗有效率为 97。44%(FAS)和 97。37%(PPS),高于对照组的 81。42%(FAS)和 81。25%(PPS)(P<0。001)。两组患者一般生命体征和实验室检测指标治疗前后均无显著性差异(P>0。05)。试验组7名受试者发生11例次不良事件,对照组4名受试者发生4例次不良事件,组间差异无统计学意义(P>0。05)。经分析,上述不良事件均可能与试验药物无关。结论 宣肺止嗽合剂治疗急性支气管炎(风邪犯肺证)临床疗效确切,可有效改善患者咳嗽症状,安全性较好。
Efficacy and Safety of Xuanfei Zhisou Mixture(宣肺止嗽合剂)for Acute Bronchitis(Wind Evil Invading Lung Type):A Randomized,Double-Blinded,Placebo and Parallel-Controlled Multicenter Trial
Objective To evaluate the safety and efficacy of Xuanfei Zhisou(宣肺止剂)for acute bronchitis of wind evil invading lung type.Methods Randomized,controlled and placebo-controlled parallel trial design was adopted,the observation was conducted in 19 parallel centers,and 240 cases were randomly divided into trial group and control group,with 120 cases in each group.The trial group was administered with Xuanfei Zhisou Mixture,while the control group was given Xuanfei Zhisou Mix-ture simulation agent.The treatment course was 7 days.The cough visual analogue scale(VAS),cough relief and disappearance,clinical efficacy and safety were compared.Results There were 232 cases completed this trial,including 118 cases in the trial group and 114 cases in the control group.After treatment,cough VAS decreased in both groups,and the VAS score of the trial group decreased greatly than that of the control group(P<0.05 or P<0.01).The differences between the 4th day after treatment and baseline,and differences between within 3 days after treatment and baseline of VAS score showed statistical significance(P<0.05 or P<0.01).The cough relief rate and disappearance rate in the trial group was higher than those in the control group(P<0.01),and the results of per protocol set(PPS)and full analysis set(FAS)were similar.The treatment efficiency in the trial group was 97.44%(FAS)and 97.37%(PPS),respectively,both were higher than those in control group[81.42%(FAS)and 81.25%(PPS)](P<0.001).There was no significant difference in general vital signs or laboratory test indexes between the two groups before and after treatment(P>0.05).In the trial group,there was 11 adverse events occurred in 7 subjects,4 adverse e-vents occurred in 4 subjects in the control group,and there were no statistical difference between two groups(P>0.05).After a-nalysis,the above adverse events may not be related to the test drug.Conclusion Xuanfei Zhisou Mixture is effective and safe in treating acute bronchitis(wind evil invading lung type),which can effectively improve the cough symptoms of patients with a good safety profile.

Xuanfei Zhisou Mixture(宣肺止嗽合剂)acute bronchitiswind evil invading lungsafetyeffectiveness

杨道文、张洪春、崔红生、高峰、封继宏、杨佩兰、罗光伟、朱佳、李明、郭栋伟、梁爱武、何咏、耿立梅、林志成、黄燕、刘杰军、赵建清、邝敏、苏海华、李兴芳、令乾、吕红霞

展开 >

中日友好医院,北京 100029

北京中医药大学第三附属医院,北京 100029

中国中医科学院望京医院,北京 100102

天津中医药大学第二附属医院,天津 300150

上海中医药大学附属岳阳中西医结合医院,上海 200437

武汉市中西医结合医院,湖北武汉 430030

江苏省中医院,江苏南京 210004

通化市中心医院,吉林 通化 134099

柳州市中医医院,广西柳州 545026

广西中医药大学附属瑞康医院,广西南宁 530011

郑州市中医院,河南郑州 450006

河北省中医院,河北石家庄 050013

白山市中医院,吉林 白山 134399

内蒙古自治区中医医院,内蒙古呼和浩特 010020

德州市人民医院,山东德州 253052

河北北方学院附属第一医院,河北 张家口 050051

南宁市第二人民医院,广西南宁 530031

新疆生产建设兵团医院,新疆乌鲁木齐 830092

甘肃省中医院,甘肃兰州 730050

甘肃普安制药股份有限公司,甘肃武威 733006

北京康义堂中医研究院,北京 101100

北京康众时代医药科技集团有限公司,北京 100070

展开 >

宣肺止嗽合剂 急性支气管炎 风邪犯肺 安全性 有效性

2025

辽宁中医杂志
辽宁中医药大学,辽宁省中医药学会

辽宁中医杂志

北大核心
影响因子:0.815
ISSN:1000-1719
年,卷(期):2025.52(1)